Latest Articles
-
PQA Creates New Social Determinants of Health Resource Guide
Guide Profiles Services That Can Improve Medication Use Quality and Safety Alexandria, Va. (January 13, 2022) – The PQA Social Determinants of Health (SDOH) Resource Guide profiles 20 real-world SDOH services that are promising for improving the quality and safety of medication use. Created by the Pharmacy Quality Alliance (PQA), the guide focuses on SDOH screenings, […] -
PQA’s Top 5 Blogs of 2021
PQA has published nearly 80 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2021, here’s a look back at the top five blogs of the year. 5. Five For Friday, March 5: Celebrating Success in Advancing Medication Use Quality (March 5) Micah Cost joined PQA as CEO on […] -
Q&A with PQA Board Member Ronna Hauser
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA’s Board members. Ronna Hauser is a PQA Board member. She […] -
2021: A Year of Milestones
Amidst an incredibly uncertain time in our world’s history, 2021 will stand out as a year of milestones. This year, we witnessed the successful deployment of several mRNA vaccines and development of therapeutics to assist in the fight against COVID-19. This effort was one of the most extraordinary feats of expedited scientific discovery and innovation […] -
Q&A with PQA Senior Director of Quality Innovation Lynn Pezzullo
PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA’s staff. Lynn Pezzullo is PQA’s Senior Director of Quality Innovation. She is responsible for […] -
Quality Forum Review: Statewide Collaboration Across Practice Settings to Improve Value-Based Care Outcomes
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals. PQA’s December 9, 2021, Quality Forum welcomed Sharrel Pinto, BSPharm, PhD, FAPhA, department head and the Hoch Endowed Professor for Community Pharmacy […] -
Pharmacy Quality Alliance Appoints 2022 Board of Directors and Executive Committee
Leaders from Diverse Healthcare Professions, Organizations and Industries Guide PQA Alexandria, Va. (December 15, 2021) – The Pharmacy Quality Alliance (PQA) Board of Directors approved its 2022 Executive Committee and appointed 11 new members to the 25-member board during its 2021 fourth quarter meeting. The appointments are effective January 1. “The PQA board is a dynamic and diverse group of visionaries and experts in health care,” Micah Cost, PharmD, […] -
PQA Endorses Pharmacy Performance Measures for Medication Adherence and Specialty Turnaround Time
Alexandria, Va. (December 20, 2021) – The Pharmacy Quality Alliance (PQA), through a majority vote of its members, has endorsed two new pharmacy performance measures. One measure evaluates adherence to three types of medications for health conditions that are major drivers of serious illness, disability, death and health care costs in the United States. The other evaluates the turnaround time of specialty pharmacy prescriptions to help patients […] -
PQA Endorses Health Plan Migraine Performance Measure and Retires Two Other Measures
Endorsed Measure Evaluates Migraine Preventive Therapy, Retired Measures Evaluated Drug-Drug Interactions and High-Risk Medication Use in Elderly Alexandria, Va. (December 20, 2021) – The Pharmacy Quality Alliance (PQA), through a majority vote of its members, has endorsed one new health plan performance measure and retired two health plan performance measures. The newly endorsed measure, Migraine Preventive Therapy (MPT), evaluates the percentage of individuals 18 years of age and older with frequent […] -
Adapting PQA’s Claims-Based Opioid Quality Measures to PDMP Data
Prescription opioid-related deaths are one of the leading preventable public health problems. High-risk prescribing practices have contributed to the opioid overdose epidemic. These include overlapping opioid and benzodiazepine prescriptions, prescribing high-dose opioids and using multiple prescribers or pharmacies for opioid prescriptions. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT […]
PQA In the News
-
Making Medication Management Services Measurable and Visible
-
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality

“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Stay Informed
Get the latest PQA news and events delivered to your inbox.


